Effect of lamotrigine on prophylaxis of pediatric classic migraine

Iranian Journal of Child Neurology

Volumn 3, Issue 2, 2009, Pages 35-38

  Mirzaei, M G R ^a   Azimian, M ^b   Moezzi, M ^a   Vameghi, R ^b   Rafieian Kopaei, M ^a  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b University of Welfare and Rehabilitation Sciences   (Iran)

Author keywords

Children; Classic migraine; Lamotringine; Migraine aura; Prophylaxis

Indexed keywords

LAMOTRIGINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; IRAN; MALE; MIGRAINE WITH AURA; PRESCHOOL CHILD; PROPHYLAXIS; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 77953472124     PISSN: 17354668     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ropper AH, Brown RH. Headache and other craniofacial pains. In: Ropper AH, Brown RH, editors. Adams and Victors principles of neurology. 8th ed. New York: McGraw Hill companies; 2005.P. 144-165
2. Haslam RHA. Headache. In: Kliegman RM, Jenson HB, Behrman RE, Stunto BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: Saunders Elsevier; 2007. P. 2479-2482
3. st ed. Florida: Merit Publishing International; 1995. P: 91-96
4. Lampl C, Katsarava Z, Diener HC, Limmroth V. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine aura. Journal of Neurology, Neurosurgery & Psychiatry 2006; 6: 54-56.
5. Sankar R, Koh S, Wu J, Menkes JH. Paroxysmal disorders. In: Menkes JH, Sarnat HB, Maria BL. editors. Child neurology. 7th ed. Philadelphia: Lippincott Williams and Wilkins; 2005. P.857-942.
6. Longoni M, Ferrarese C. Inflammation and excitotoxicity: role in migraine pathogenesis. Neurological Sciences 2006; 27: 107-110
7. Vaccaro M, Riva C, Tremolizzo L, Longoni M. Platelet glutamate uptake and release in migraine with and without aura. Cephalalgia 2007; 27 (1): 35-40.
8. Lauritzen M. Pathophysiology of the migraine aura, the spreading depression theory. Brain Oxford Journal 1994; 117 (1): 199-210.
9. Andrea GD, Allais G, Grazzi L. Migraine with aura: from pathophysiology to treatment: therapeutic strategies. J Neurological Sciences 2005; 26: 104-107
10. Stephen D, Silberstein MD. FACP. American Academy of neurology. 57th annual meeting. April 2005; Miami Beach, Florida.
11. Pellock JM. Lamotringine. In: Pellock JM, Bargeois FD, Dodson WE. editors. Pediatric epilepsy: diagnosis and therapy 3rd ed. New York: Demos; 2008. P. 603-609
12. Stephen D, Silberstein MD. Preventive treatment of migraine. Trends in Pharmacological Sciences 2006; 77 (8): 410-415
13. Cananzi AR, Andrea GD, Perini F. Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia 1995; 15 (2): 132-135
14. Gupta P, Singh S. Goyal V. Shukla G Behari M. Low dose topiramate versus lamotrigine in migraine prophylaxis (the lotolamp study). Headache 2007; 47: 402-412
15. Andrea GD, Granella F, Cudaldini M. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia 1999; 19: 64-66
16. Lampl C, Buzath A, limger DK, Neamann K. Lamotrigine in the prophylactic treatment of migraine aura: a pilot study. Cephalalgia 1999; 19: 58-63.
17. Richard B. Lipton JM. Epidemiology and classification of headache. In: Winner P, Rothner AD, editors. Headache in children and adolescent. London: Bc Decker INC Hamilton. 2001. P. 87-114.
18. + currents in cortical neurons: functional implications. Eur J Pharmacol 1996; 307: 113-116.
19. Wang SJ, Tsai JJ, Gean PW. Lamotrigine inhibits depolarization-evoked Ca influx in dissociated amygdale neurons. Synapse 1998; 29: 355-362.